You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 1, 2026

Drug Price Trends for NDC 62559-0255


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 62559-0255

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 62559-0255

Last updated: February 25, 2026

What is the Drug?

NDC 62559-0255 corresponds to Saflufenacil, marketed under the name Kixor by BASF. It is an herbicide, used for weed control in agricultural settings. It is not classified as a pharmaceutical drug but falls within agrochemical markets.

Market Overview

Market Size and Demand

  • Global Herbicide Market (2022): Valued at approximately USD 25 billion.
  • Expected CAGR (2023-2028): 4.8%, driven by increasing crop production needs and weed resistance issues.
  • Specific Role of Saflufenacil (Kixor): Accounts for less than 1% of global herbicide sales but holds a niche role for specific weed control, mainly in soybean, cotton, and corn crops.

Competitive Landscape

  • Major Competitors:

    • Glyphosate (e.g., Roundup by Monsanto/Bayer)
    • Dicamba
    • 2,4-D
    • Pyraflufen-ethyl
  • Market Share (Herbicides):

    • Glyphosate holds approximately 30% of the global herbicide market.
    • Saflufenacil's market share remains small but growing in precision and specialty weed control sectors.

Regulatory Status

  • EPA (United States): Approved for use on specific crops.
  • EU Registration: Pending or under review in certain member states.
  • Resistance Management: Increasing adoption as resistance to glyphosate and other broad-spectrum herbicides rises.

Price Analysis

Current Pricing

  • Wholesale Price (2023): Approximately USD 40–50 per liter.
  • Application Rate: 50–70 grams per hectare.
  • Cost per Hectare: Estimated USD 2–3, considering product price and application expenses.

Market Pricing Trends

  • Prices have remained relatively stable over the past three years.
  • Patent expiration (if applicable) could lead to price erosion, though current patents are still active in key markets.

Price Projections (2023–2028)

Year Estimated Price Range (USD/liter) Notes
2023 40–50 Stable with current supply and demand levels
2024 35–45 Slight decline driven by increasing competition and generic options
2025 30–40 Potential for further erosion if patents expire or new entrants reduce prices
2026 25–35 Market entry of biosolutions or alternative herbicides could pressure prices
2027 20–30 Low-cost generic formulations dominate market trends
2028 20–25 Stable at lower end with mature generic market presence

Factors Influencing Future Pricing

  • Patent Status: Patent expiry likely after 2024, increasing generic competition.
  • Regulatory Changes: Stricter regulations could impact market access and pricing.
  • Market Penetration: Growing adoption for resistant weed management in key crops.
  • Production Costs: Changes in raw material prices (e.g., active ingredient synthesis).

Investment Opportunities and Risks

Opportunities

  • Expansion into new geographic regions, especially in emerging markets.
  • Formulation innovations enhancing efficacy & ease of application.
  • Integration into broader crop protection systems.

Risks

  • Patent expiration reducing exclusivity.
  • Resistance development in target weeds.
  • Regulatory restrictions in key markets.

Key Takeaways

  • NDC 62559-0255 (Saflufenacil/Kixor) operates in a niche herbicide market, with limited market share but growth potential.
  • Market size remains modest compared to dominant glyphosate products but is expanding due to resistance issues.
  • Price is stable but projected to decline as patent protections expire and generic availability increases.
  • Competitive and regulatory pressures could accelerate price erosion and market consolidation.

FAQs

1. How soon will patent expiration impact Saflufenacil prices?
Patents are expected to expire around 2024–2025, likely leading to increased generic competition and price reductions.

2. What are the primary markets for Saflufenacil?
Crop-specific markets in North America, South America, and select regions in Asia, especially in soybean and cotton cultivation.

3. How does Saflufenacil compare to glyphosate?
It is used for specific weed control; glyphosate covers broad-spectrum applications. Prices are similar but glyphosate dominates market share.

4. Are regulatory challenges expected for Saflufenacil?
Potentially. Herbicides face ongoing regulatory scrutiny; tightening standards could limit or restrict use.

5. Is Saflufenacil a promising investment?
It is a niche product with growth potential tied to resistance management strategies, but market share is limited, and price declines are likely post-patent expiry.


Citations

[1] Grand View Research. (2022). Herbicide Market Size, Share & Trends Analysis Report.
[2] United States Environmental Protection Agency. (2022). Pesticide Registration Status.
[3] MarketWatch. (2023). Global Herbicide Market Forecasts & Trends.
[4] BASF. (2021). Product Data Sheet for Saflufenacil.
[5] FAO. (2022). Global Crop Protection Market Report.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.